Andrea Riccardo Filippi

Full Professor

University of Pavia

Italy

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Pakistani students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Medical Imaging

50%

Pharmacotherapy

80%

Oncology

100%

Cancer Therapy

70%

Neoadjuvant Therapy

50%

Cancer Biology

50%

Radiation Therapy

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles20

Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R

Article Link

Year:

2024

Toward a paradigm shift in prognostication and treatment of early-stage Hodgkin lymphoma.

Article Link

Year:

2024

A Glimpse Into the Future for Unresectable Stage III Non-Small Cell Lung Cancer

Article Link

Year:

2024

CT and MRI radiomic features of lung cancer (NSCLC): comparison and software consistency

Article Link

Year:

2024

Future perspectives of radiation therapy for Hodgkin Lymphoma: Risk-adapted, response-adapted, and safer than before

Article Link

Year:

2024

MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable Stage IIB–IIIB NSCLC

Article Link

Year:

2024

Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approach

Article Link

Year:

2024

The Role of Native T1 and T2 Mapping Times in Identifying PD-L1 Expression and the Histological Subtype of NSCLCs

Article Link

Year:

2023

Editorial: Imaging assessment of response to immunotherapy

Article Link

Year:

2023

New options and open issues in the management of unresectable stage III and in early-stage NSCLC: A report from an expert panel of Italian medical and radiation oncologists – INTERACTION group

Article Link

Year:

2023

Performance of an AI algorithm during the different phases of the COVID pandemics: what can we learn from the AI and vice versa.

Article Link

Year:

2023

Correlation between PD-L1 Expression of Non-Small Cell Lung Cancer and Data from IVIM-DWI Acquired during Magnetic Resonance of the Thorax: Preliminary Results.

Article Link

Year:

2022

‘Le Roi est mort, vive le Roi’: New Roles of Radiotherapy in the Treatment of Lymphomas in Combination With Immunotherapy

Article Link

Year:

2022

Almost one year of COVID-19 pandemic: how radiotherapy centers have counteracted its impact on cancer treatment in Lombardy, Italy. CODRAL/AIRO-L study

Article Link

Year:

2022

An integrated approach to cardioprotection in lymphomas

Article Link

Year:

2022

Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era

Article Link

Year:

2022

Preliminary report on harmonization of features extraction process using the ComBat tool in the multi-center “Blue Sky Radiomics” study on stage III unresectable NSCLC

Article Link

Year:

2022

Unmet needs in the management of unresectable stage III non-small cell lung cancer: a review after the ‘radio talk’ webinars

Article Link

Year:

2022

A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin’s Lymphoma

Article Link

Year:

2021

DUART: durvalumab after radiotherapy in patients with unresectable, stage III NSCLC who are ineligible for chemotherapy

Article Link

Year:

2021

Collaborators10

Michela BUGLIONE DI MONALE E BASTIA

Prof

University of Brescia

ITALY

Daniel C. Christoph

Chief of Division

GERMANY

Pilar Garrido López

Head Medical Oncology Department

HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL

SPAIN

Lorenzo Preda

University of Pavia

ITALY

Maja Vestmø Maraldo

Copenhagen University Hospital

DENMARK

John Field

Clinical Professor of Molecular Oncology

UNITED KINGDOM

Giulia M. Stella

ITALY

Chandra Bortolotto

ITALY

Anna Santacaterina

Chief of Radiation Oncology

ITALY

Marta Scorsetti

Full Professor in Diagnostic Imaging and Radiotherapy

Humanitas University

ITALY

How do Pakistani students reach out?

Meet Kite AI